The company utilized kidney-on-a-chip technology (based on Organ-on-a-Chip model) to study established kidney injury biomarkers, including KIM-1, cystatin C, NAG, and NGAL, in response to polymyxin-B, ...

VRP-034 is a novel formulation of the antibiotic polymyxin B sulphate, developed by Venus Medicine Research Centre (VMRC), the company's R&D division. It aims to reduce the severe kidney toxicity ...

Brownlee, G., and Bushby, S. R. M., Lancet, (i), 127 (1948). Bell, P. H., Bone, J. F., English, J. P., Fellows, C. E., Howard, K. S., Rogers, M. M., Shepherd, R. G ...

A breakthrough new antibiotic has been discovered to help tackle the rise of super gonorrhoea. Scientists have found the first new antibiotic treatment for gonorrhoea since the 1990s as a worrying ...

Gepotidacin, an antibiotic currently used to treat urinary tract infections, could be a new treatment to treat gonorrhea, protecting against the threat of treatment-resistant gonorrhea and ...